1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
|||
a)
|
Name
|
Mark
Mallon
|
||
2
|
Reason for the notification
|
|||
a)
|
Position/status
|
Person
Discharging Managerial Responsibilities
|
||
b)
|
Initial
notification /Amendment
|
Initial
notification
|
||
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|||
a)
|
Name
|
AstraZeneca
PLC
|
||
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
|
||
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|||
a)
|
Description
of the financial instrument, type of instrument
Identification
code
|
AstraZeneca
PLC American Depositary Shares
CUSIP:
046353108
|
||
b)
|
Nature
of the transaction
|
Sale of
AstraZeneca PLC American Depositary Shares
|
||
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
US$
33.900214
|
20,000
|
|||
d)
|
Aggregated
information
-
Aggregated volume
-
Price
|
Not
applicable - single transaction
|
||
e)
|
Date of
the transaction
|
23 May
2017
|
||
f)
|
Place
of the transaction
|
NYSE
|
Media Enquiries
|
|
|
Esra
Erkal-Paler
|
UK/Global
|
+44 203 749
5638
|
Karen
Birmingham
|
UK/Global
|
+44 203 749
5634
|
Rob
Skelding
|
UK/Global
|
+44 203 749
5821
|
Jacob
Lund
|
Sweden
|
+46 8 553 260
20
|
Michele
Meixell
|
US
|
+1 302 885
2677
|
Investor Relations
|
|
|
Thomas Kudsk
Larsen
|
|
+44 203 749
5712
|
Craig
Marks
|
Finance,
Fixed Income, M&A
|
+44 7881 615
764
|
Henry
Wheeler
|
Oncology
|
+44 203 749
5797
|
Mitchell
Chan
|
Oncology
|
+1 240
477 3771
|
Lindsey
Trickett
|
Cardiovascular
& Metabolic Diseases
|
+1 240
543 7970
|
Nick
Stone
|
Respiratory
|
+44 203 749
5716
|
Christer
Gruvris
|
Autoimmunity,
Neuroscience & Infection
|
+44 203 749
5711
|
US toll
free
|
|
+1 866
381 7277
|
Date:
24 May 2017
|
By: /s/
Adrian Kemp
|
|
Name:
Adrian Kemp
|
|
Title:
Company Secretary
|